- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03720691
rTMS-behandling ved vaskulær parkinsonisme (rTMS)
Effekt av repeterende transkraniell magnetisk stimulering i vaskulær parkinsonisme
Vascular parkinsonism (VP), parkinsonism resulting from ischemic cerebrovascular disease, was suggested in 1929. The main features are wide-based gait, postural instability, and falls, which make patients with VP frustrated. Currently, the treatment is challenging.
Transcranial magnetic stiumation is a noninvasive procedure using electromagnetic induction to stimulate brain, and repetitive transcranial magnetic stiumation (rTMS) can selectively change brain activity to enhance desired effects. The aim of this study is to explore the therapeutic effect of rTMS for the VP.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
-
Primary outcome
- The number of steps
-
Secondary outcome
- UPDRS part III - motor part
- Finger tapping test with right hand
- The completion time during the SWS test
- Freezing episodes of gait trajectory (two tasks)
- Clinical Global Impression Scale
- Patient's Global Impression Scale
Studietype
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Busan, Sør -Korea
- Inje university, Busan Paik Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Vascular parkinsonism
- age 18 and older
Exclusion Criteria:
- pregnant or any, other medical, surgical, neurological or psychiatric conditions
- other restrictions which prevent you from undergoing TMS recording, such as; surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), and/ or heart/cardiac lines
- any past or current history of seizure disorder or epilepsy
- unable to give informed consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Real rTMS Supplementary motor area
Real rTMS will be applied over the supplementary motor area |
There will be a series of four rTMS blocks separated by 10 minutes. Each block will consist of 15 to 25 pulse trains of 1-second duration at 25 Hz, with an intertrain interval of 10 seconds.
Andre navn:
|
|
Sham-komparator: Sham rTMS Supplementary motor area
Sham rTMS will be applied over the supplementary motor area |
There will be no real brain stimulation in Sham rTMS, and participant will be blinded.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Unified Parkinson's Disease Rating Scale (UPDRS) part III-motor part (Number 18 ~31 of UPDRS)
Tidsramme: 2 days
|
Motor functions will be checked using UPDRS. Each item of the motor part ranges from 0 to 4 (0 means normal, 4 means worst condition). Total sum will be calculated. |
2 days
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Finger tapping test with right hand
Tidsramme: 2 days
|
Finger tapping test with right hand, as quickly as possible for 15 second. The total number of taps will be calculated. The test will be twice with one minute interval. After the test performed twice, the average of the tests will be used. |
2 days
|
|
The total number of steps during the stand-walk-sit (SWS) test
Tidsramme: 2 days
|
SWS test is Standing up, making a 9 m round trip, and sitting down as quickly as possible. The number of steps will be recorded. |
2 days
|
|
The completion time during the SWS test
Tidsramme: 2 days
|
The completion time will be recorded. |
2 days
|
|
Freezing episodes of gait trajectory
Tidsramme: 2 days
|
The number of freezing episodes during rapid full turns and dual task |
2 days
|
|
Patient and Clinical Global Impression Scale
Tidsramme: 2 days
|
7-point scale that requires the patient (or clinician) to rate the response of the interventions. The rating will be numbered (1: very much improved; 2: much improved; 3: minimally improved; 4: no changes; 5: minimally worse; 6: much worse; 7: very much worse). |
2 days
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Sang Jin Kim, MD, PhD, Inje Unversity, Busan Paik Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 18-0089
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .